Abstract
Glutathione S-transferase Pi (GST P) has been reported to be a marker of dysplastic lesions. For this reason expression of GST P by intraduct breast carcinoma was evaluated by immunohistochemistry. Thirty-seven of 92 carcinomas (40%) were GST P positive. GST P staining did not correlate with histological variables, c-erbB-2 overexpression or with clinical outcome. The GST P status of recurrences did not correlate with that of the index lesion. There is little evidence that GST P is a useful marker of the potential of intraduct breast carcinoma to become invasive.
| Original language | English |
|---|---|
| Pages (from-to) | 183-185 |
| Number of pages | 3 |
| Journal | British Journal of Cancer |
| Volume | 69 |
| Issue number | 1 |
| Publication status | Published - Jan 1994 |
Keywords
- Adult
- Aged
- Breast neoplasms
- Carcinoma in situ
- Carcinoma, ductal, breast
- Evaluation studies as topic
- Female
- Follow-up studies
- Gene expression
- Glutathione Transferase
- Humans
- Immunohistochemistry
- Isoenzymes
- Middle aged
- Proto-oncogene proteins
- Receptor, epidermal growth factor
- Receptor, erbB-2
Access to Document
- bellamy1994bjc183
Copyright Macmillan Press Ltd., 1994. Full text is available as a scanned copy of the original print version from Europe PubMed Central PMC1968756